Access to this 750mcg Teriparatide Injection formulation within AU is presently . Although it is approved for use to treat osteoporosis, distribution of this specific formulation are relatively restricted . Physicians might need to apply specific permission from a appropriate pathway to obtain it for patient's patients . A important consideration t